October 2020 Webinar
New and Emerging Trends in CLL Drug Therapy and the Pharmacist’s Role in Patient Care (Pharmacy Times CE)
Date/Time: October 6, 2020 from 7:00 PM to 8:00 PM ET
Bernard L. Marini, PharmD, BCOP
Clinical Pharmacist Specialist – Hematology
Department of Pharmacy
Universiry of Michigan – Michigan Medicine
Pharmacists & Technicians
- Explain how specific genetic canter abnormalities may affect treatment selection for a patient with CLL
- Construct the appropriate treatment regimen for a patient with CLL based on patient-specific factors and safety and efficacy data
- Devise a plan to coordinate the care of a patient being treated for CLL with both an IV and oral anticancer therapy
Health-system pharmacists, technicians, and pharmacy students. This is a knowledge-based program. There is no charge for members of the LISHP.
Pharmacist Accreditation Statement:
Pharmacy Times Continuing Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1 contact hour (0.1 CEU) under the ACPE universal activity number 0290-0000-20-091-L01-P. The activity is available for CE credit through December 6, 2020.
Please check the NYSCHP website for upcoming educational content!
Resources for COVID-19 can be found here
Please contact Sebastian Choi (email@example.com) if you have any questions.